Literature DB >> 25220596

Critical role of NKT cells in posttransplant alloantibody production.

J M Zimmerer1, P Swamy, P B Sanghavi, C L Wright, M Abdel-Rasoul, S M Elzein, R R Brutkiewicz, G L Bumgardner.   

Abstract

We previously reported that posttransplant alloantibody production in CD8-deficient hosts is IL-4+ CD4+ T cell-dependent and IgG1 isotype-dominant. The current studies investigated the hypothesis that IL-4-producing natural killer T cells (NKT cells) contribute to maximal alloantibody production. To investigate this, alloantibody levels were examined in CD8-deficient WT, CD1d KO and Jα18 KO transplant recipients. We found that the magnitude of IgG1 alloantibody production was critically dependent on the presence of type I NKT cells, which are activated by day 1 posttransplant. Unexpectedly, type I NKT cell contribution to enhanced IgG1 alloantibody levels was interferon-γ-dependent and IL-4-independent. Cognate interactions between type I NKT and B cells alone do not stimulate alloantibody production. Instead, NKT cells appear to enhance maturation of IL-4+ CD4+ T cells. To our knowledge, this is the first report to substantiate a critical role for type I NKT cells in enhancing in vivo antibody production in response to endogenous antigenic stimuli. © Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25220596      PMCID: PMC4207222          DOI: 10.1111/ajt.12922

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  75 in total

1.  The inductive effect of interleukin-4 on IgG4 and IgE synthesis in human peripheral blood lymphocytes.

Authors:  A Ishizaka; Y Sakiyama; M Nakanishi; K Tomizawa; E Oshika; K Kojima; Y Taguchi; E Kandil; S Matsumoto
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

2.  Rejection responses to allogeneic hepatocytes by reconstituted SCID mice, CD4, KO, and CD8 KO mice.

Authors:  G L Bumgardner; D Gao; J Li; J H Baskin; M Heininger; C G Orosz
Journal:  Transplantation       Date:  2000-12-27       Impact factor: 4.939

3.  Type II NKT cells facilitate Alum-sensing and humoral immunity.

Authors:  Hemangi B Shah; T Scott Devera; Pragya Rampuria; Gillian A Lang; Mark L Lang
Journal:  J Leukoc Biol       Date:  2012-07-13       Impact factor: 4.962

4.  Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs.

Authors:  G Strauss; W Osen; K-M Debatin
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

Review 5.  The immunoregulatory role of type I and type II NKT cells in cancer and other diseases.

Authors:  Masaki Terabe; Jay A Berzofsky
Journal:  Cancer Immunol Immunother       Date:  2014-01-03       Impact factor: 6.968

6.  Risk factors for capillary C4d deposition in kidney allografts: evaluation of a large study cohort.

Authors:  Matthias Lorenz; Heinz Regele; Martin Schillinger; Markus Exner; Susanne Rasoul-Rockenschaub; Markus Wahrmann; Josef Kletzmayr; Gerd Silberhumer; Walter H Hörl; Georg A Böhmig
Journal:  Transplantation       Date:  2004-08-15       Impact factor: 4.939

7.  FcgammaRIII (CD16)-deficient mice show IgG isotype-dependent protection to experimental autoimmune hemolytic anemia.

Authors:  D Meyer; C Schiller; J Westermann; S Izui; W L Hazenbos; J S Verbeek; R E Schmidt; J E Gessner
Journal:  Blood       Date:  1998-12-01       Impact factor: 22.113

8.  Role of CD40 antigen and interleukin-2 in T cell-dependent human B lymphocyte growth.

Authors:  D Blanchard; C Gaillard; P Hermann; J Banchereau
Journal:  Eur J Immunol       Date:  1994-02       Impact factor: 5.532

Review 9.  Immunoglobulin G4: an odd antibody.

Authors:  R C Aalberse; S O Stapel; J Schuurman; T Rispens
Journal:  Clin Exp Allergy       Date:  2009-02-13       Impact factor: 5.018

10.  Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16).

Authors:  W L Hazenbos; I A Heijnen; D Meyer; F M Hofhuis; C R Renardel de Lavalette; R E Schmidt; P J Capel; J G van de Winkel; J E Gessner; T K van den Berg; J S Verbeek
Journal:  J Immunol       Date:  1998-09-15       Impact factor: 5.422

View more
  5 in total

1.  Critical Role of Macrophage FcγR Signaling and Reactive Oxygen Species in Alloantibody-Mediated Hepatocyte Rejection.

Authors:  Jason M Zimmerer; Xin L Liu; Alecia Blaszczak; Christina L Avila; Thomas A Pham; Robert T Warren; Ginny L Bumgardner
Journal:  J Immunol       Date:  2018-11-05       Impact factor: 5.422

2.  Invariant NKT Cells Promote the Development of Highly Cytotoxic Multipotent CXCR3+CCR4+CD8+ T Cells That Mediate Rapid Hepatocyte Allograft Rejection.

Authors:  Jason M Zimmerer; Bryce A Ringwald; Sachi R Chaudhari; Jing Han; Chelsea M Peterson; Robert T Warren; Madison M Hart; Mahmoud Abdel-Rasoul; Ginny L Bumgardner
Journal:  J Immunol       Date:  2021-11-22       Impact factor: 5.426

3.  Re-programming mouse liver-resident invariant natural killer T cells for suppressing hepatic and diabetogenic autoimmunity.

Authors:  Channakeshava Sokke Umeshappa; Patricia Solé; Jun Yamanouchi; Saswat Mohapatra; Bas G J Surewaard; Josep Garnica; Santiswarup Singha; Debajyoti Mondal; Elena Cortés-Vicente; Charlotte D'Mello; Andrew Mason; Paul Kubes; Pau Serra; Yang Yang; Pere Santamaria
Journal:  Nat Commun       Date:  2022-06-07       Impact factor: 17.694

4.  Unique CD8+ T Cell-Mediated Immune Responses Primed in the Liver.

Authors:  Jason M Zimmerer; Phillip H Horne; Mason G Fisher; Thomas A Pham; Keri E Lunsford; Bryce A Ringwald; Christina L Avila; Ginny L Bumgardner
Journal:  Transplantation       Date:  2016-09       Impact factor: 4.939

Review 5.  Activation and Regulation of B Cell Responses by Invariant Natural Killer T Cells.

Authors:  Derek G Doherty; Ashanty M Melo; Ana Moreno-Olivera; Andreas C Solomos
Journal:  Front Immunol       Date:  2018-06-18       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.